Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Waterloo

$25,000.00

Development of protocols to optimize the analysis of biological fluids by capillary electrophoresis

EF 2014-15

Résumé
Although the prevalence and broad impact of mental illness has attracted substantial research attention, ourknowledge of how and why they develop is still quite limited. One major obstacle to theimproved understanding and treatment of mental illness concerns the highly variable and subjective clinicalguidelines used to identify and track these diseases. As a result, the development of technologies to permitthe specific, sensitive, and quantitative identification of b iomarkers for mental illnesses would b e ofconsiderab le b enefit. We propose to develop a novel screening tool for a variety of bodily fluids (blood, saliva,and urine) relevant to the detection and quantification of mental illness biomarkers using capillaryelectrophoresis with whole-column imaging detection (CE-WCID) in partnership with a local instrumentmanufacturer, Advanced Electrophoresis Solutions (AES).Advanced Electrophoresis Solutions provides unique approaches for protein characterisation-relatedresearch based on whole-column imaging detection capillary electrophoresis. Electrophoresis is a procedurethat separates proteins from each other, and is a common technology used in applications spanning fieldsfrom agriculture to pharmaceutical development. The capillary electrophoresis platform developed by AES isbased on whole column imaging detection (WCID) technology, a novel method that monitors the entirecapillary during electrophoresis. CE-WCID offers a promising yet unrecognized platform for continuousmonitoring of fast kinetic processes in free solution, and, consequently, offers various research capabilitiesthat cannot be achieved with any other technology. By creating and optimising protocols that will allow thesensitive, cutting edge technology, made available by AES to identify mental illness relevant biomarkersisolated from bodily fluids, we are confident that we can build the foundation required for the developmentof new tools to diagnose mental health illness using biomarkers.Overall, our work will showcase the uniquemerits of CE-WCID for high-quality screening of mental illness biomarkers in body fluids that is urgentlyneeded for improved mental illness diagnostics based on biomarkers. This project will also provide AES aninnovative application to expand commercial interests in marketing their technology that is of majorsignificance to developing novel diagnostic tools and the global bio-pharmaceutical industry.
Programme
Engage Grants Program
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
466999-2014
Name nom
Mielke, John
Department département
Public Health and Health Systems, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Development of protocols to optimize the analysis of biological fluids by capillary electrophoresis
Keyword
NSERC
Application summary
Although the prevalence and broad impact of mental illness has attracted substantial research attention, ourknowledge of how and why they develop is still quite limited. One major obstacle to theimproved understanding and treatment of mental illness concerns the highly variable and subjective clinicalguidelines used to identify and track these diseases. As a result, the development of technologies to permitthe specific, sensitive, and quantitative identification of b iomarkers for mental illnesses would b e ofconsiderab le b enefit. We propose to develop a novel screening tool for a variety of bodily fluids (blood, saliva,and urine) relevant to the detection and quantification of mental illness biomarkers using capillaryelectrophoresis with whole-column imaging detection (CE-WCID) in partnership with a local instrumentmanufacturer, Advanced Electrophoresis Solutions (AES).Advanced Electrophoresis Solutions provides unique approaches for protein characterisation-relatedresearch based on whole-column imaging detection capillary electrophoresis. Electrophoresis is a procedurethat separates proteins from each other, and is a common technology used in applications spanning fieldsfrom agriculture to pharmaceutical development. The capillary electrophoresis platform developed by AES isbased on whole column imaging detection (WCID) technology, a novel method that monitors the entirecapillary during electrophoresis. CE-WCID offers a promising yet unrecognized platform for continuousmonitoring of fast kinetic processes in free solution, and, consequently, offers various research capabilitiesthat cannot be achieved with any other technology. By creating and optimising protocols that will allow thesensitive, cutting edge technology, made available by AES to identify mental illness relevant biomarkersisolated from bodily fluids, we are confident that we can build the foundation required for the developmentof new tools to diagnose mental health illness using biomarkers.Overall, our work will showcase the uniquemerits of CE-WCID for high-quality screening of mental illness biomarkers in body fluids that is urgentlyneeded for improved mental illness diagnostics based on biomarkers. This project will also provide AES aninnovative application to expand commercial interests in marketing their technology that is of majorsignificance to developing novel diagnostic tools and the global bio-pharmaceutical industry.